Randomized Trialhigh evidence
Fecal microbiota transplantation-based treatment protocol for chronic insomnia disorder: A randomized, double-blind, placebo-controlled trial.
Journal of internal medicine·July 22, 2026·PMID 42482568
Why it mattersChronic insomnia is prevalent and often inadequately managed with current therapies. This trial provides high-level evidence that gut microbiome modulation via FMT can improve both objective and subjective sleep measures, offering a novel therapeutic avenue for specialists managing sleep disorders or exploring gut-brain axis interventions.
The papers that matter, first.
MedLit ranks the medical literature into a specialty feed with concise summaries, evidence-aware triage, and visual takeaways.
§
MedLit · Evidence, Distilled